chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Stomach Ache; Headache; Fatigue; pain in the injection site; chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach Ache), HEADACHE (Headache), FATIGUE (Fatigue), INJECTION SITE PAIN (pain in the injection site) and CHILLS (chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach Ache), HEADACHE (Headache), FATIGUE (Fatigue), INJECTION SITE PAIN (pain in the injection site) and CHILLS (chills). At the time of the report, ABDOMINAL PAIN UPPER (Stomach Ache), HEADACHE (Headache), FATIGUE (Fatigue), INJECTION SITE PAIN (pain in the injection site) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 19apr2021, No new information
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Catheter management, Computerised tomogram, Hypokinesia, Magnetic resonance imaging head, Magnetic resonance imaging heart
Clinical narrative: Severe muscle weakness couldn't move arms nor legs; Loose palm movement; He has a super pubic tube and the bag wasn't very clean; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Severe muscle weakness couldn't move arms nor legs), HYPOKINESIA (Loose palm movement) and CATHETER MANAGEMENT (He has a super pubic tube and the bag wasn't very clean) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced MUSCULAR WEAKNESS (Severe muscle weakness couldn't move arms nor legs), HYPOKINESIA (Loose palm movement) and CATHETER MANAGEMENT (He has a super pubic tube and the bag wasn't very clean). On 30-Jan-2021, MUSCULAR WEAKNESS (Severe muscle weakness couldn't move arms nor legs) and HYPOKINESIA (Loose palm movement) had resolved. At the time of the report, CATHETER MANAGEMENT (He has a super pubic tube and the bag wasn't very clean) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: unknown (Inconclusive) Inconclusive. On an unknown date, Magnetic resonance imaging head: negative (Negative) Negative. On an unknown date, Magnetic resonance imaging heart: negative (Negative) Negative. On an unknown date, X-ray: unknown (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: NNI
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, X-ray
Clinical narrative: Severe muscle weakness couldn't move arms nor legs; Loose palm movement; He has a super pubic tube and the bag wasn't very clean; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Severe muscle weakness couldn't move arms nor legs), HYPOKINESIA (Loose palm movement) and CATHETER MANAGEMENT (He has a super pubic tube and the bag wasn't very clean) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced MUSCULAR WEAKNESS (Severe muscle weakness couldn't move arms nor legs), HYPOKINESIA (Loose palm movement) and CATHETER MANAGEMENT (He has a super pubic tube and the bag wasn't very clean). On 30-Jan-2021, MUSCULAR WEAKNESS (Severe muscle weakness couldn't move arms nor legs) and HYPOKINESIA (Loose palm movement) had resolved. At the time of the report, CATHETER MANAGEMENT (He has a super pubic tube and the bag wasn't very clean) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: unknown (Inconclusive) Inconclusive. On an unknown date, Magnetic resonance imaging head: negative (Negative) Negative. On an unknown date, Magnetic resonance imaging heart: negative (Negative) Negative. On an unknown date, X-ray: unknown (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: NNI
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Sleep disorder
Clinical narrative: went to bed early; woke up with severe diarrhea; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (went to bed early), DIARRHOEA (woke up with severe diarrhea) and NAUSEA (nauseous) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20a and 023L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 02-Jan-2021, the patient experienced NAUSEA (nauseous). On an unknown date, the patient experienced SLEEP DISORDER (went to bed early) and DIARRHOEA (woke up with severe diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) ongoing since an unknown date for Diarrhea, at a dose of UNK dosage form. At the time of the report, SLEEP DISORDER (went to bed early), DIARRHOEA (woke up with severe diarrhea) and NAUSEA (nauseous) outcome was unknown.            No concomitant medications were reported.  Treatment medication included 2 doses of Immodium.  Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Eyelid irritation, Fatigue, Pain in extremity, Respiratory rate increased
Clinical narrative: fast breathing; fatigue; arm sorennes; left eyelid irritated; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sorennes), EYELID IRRITATION (left eyelid irritated), RESPIRATORY RATE INCREASED (fast breathing) and FATIGUE (fatigue) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm sorennes), EYELID IRRITATION (left eyelid irritated) and FATIGUE (fatigue). On 02-Feb-2021, the patient experienced RESPIRATORY RATE INCREASED (fast breathing). At the time of the report, PAIN IN EXTREMITY (arm sorennes), EYELID IRRITATION (left eyelid irritated), RESPIRATORY RATE INCREASED (fast breathing) and FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concominant and treatment drugs were not provided. lab data and historical conditions were also not provided
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: red spot as big as a half dollar; itchy; swelling; redness at the site; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (red spot as big as a half dollar), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (redness at the site) and VACCINATION SITE SWELLING (swelling) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Cholesterol and Arthritis. Concomitant products included ALLOPURINOL for Arthritis, ATORVASTATIN for Cholesterol, INSULIN DETEMIR (LEVEMIR) and SITAGLIPTIN PHOSPHATE (JANVIA) for Diabetes mellitus, CALCIUM and MULTIVITAMINS [VITAMINS NOS] for Supplementation therapy, HCTZ for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the site). On 30-Jan-2021, the patient experienced RASH MACULAR (red spot as big as a half dollar), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE SWELLING (swelling). The patient was treated with HYDROCORTISONE at a dose of UNK, tid. On 28-Jan-2021, VACCINATION SITE ERYTHEMA (redness at the site) had resolved. At the time of the report, RASH MACULAR (red spot as big as a half dollar), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE SWELLING (swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache/ shooting pains in head; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache/ shooting pains in head) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced HEADACHE (Headache/ shooting pains in head). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache/ shooting pains in head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to touch at the injection site; Itching at the injection site; Redness at the injection site; Muscle soreness at the injection site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PAIN (Muscle soreness at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PAIN (Muscle soreness at the injection site). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK dosage form (used for first two days). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site), VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE PAIN (Muscle soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. The patient took Advil for the first two days.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose, Blood pressure measurement, Chills, Hyperhidrosis
Clinical narrative: Sweating; weakness; Chills; Low blood pressure of 100/51; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure of 100/51), HYPERHIDROSIS (Sweating), ASTHENIA (weakness) and CHILLS (Chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Hyperlipidemia in 1995 and Stroke (2 strokes) in 2010. Concurrent medical conditions included Blood pressure high since 1998, Diabetes since 2008, Benign prostatic hyperplasia (chronic condition worsening) since 1990 and Neuropathy (chronic condition worsening) since 2008. Concomitant products included TAMSULOSIN from 1990 to an unknown date, LISINOPRIL from 1998 to an unknown date, PRAVASTATIN SODIUM, GLIPIZIDE from 2008 to an unknown date, CARVEDILOL from 1998 to an unknown date, METFORMIN, CLOPIDOGREL, AMLODIPINE BESYLATE and CHONDROITIN SULFATE, GLUCOSAMINE (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE]) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced HYPOTENSION (Low blood pressure of 100/51). On 30-Jan-2021, the patient experienced HYPERHIDROSIS (Sweating), ASTHENIA (weakness) and CHILLS (Chills). On 01-Feb-2021, HYPOTENSION (Low blood pressure of 100/51) had resolved. At the time of the report, HYPERHIDROSIS (Sweating), ASTHENIA (weakness) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Blood glucose: 188 (Inconclusive) 188. On 29-Jan-2021, Blood pressure measurement: 100/51 (Low) 100/51 blood pressure has been going high and low and has not taken his BP medicines..     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment medication was taken. Patient stated that she didn't take blood pressure medication at that night.   This case was linked to MOD-2021-082574 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow-up received on 19-Apr-2021. The patient provided his Race as White and Ethnicity as Not Hispanic or Latino. The patient provided Medical history details  with High blood pressure and Diabetes as ongoing, Hyperlipidemia as no recent change in status of chronic condition, Benign Prostatic hyperplasia and Neuropathy as in worsening  status of chronic condition and the patient also had 2 strokes in the past. The patient provided the second dose details. The patient also provided several concomitant medication details. The adverse event outcome of Low BP after first dose and second dose was recovered.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: Sweating; weakness; Chills; Low blood pressure of 100/51; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure of 100/51), HYPERHIDROSIS (Sweating), ASTHENIA (weakness) and CHILLS (Chills) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included Hyperlipidemia in 1995 and Stroke (2 strokes) in 2010. Concurrent medical conditions included Blood pressure high since 1998, Diabetes since 2008, Benign prostatic hyperplasia (chronic condition worsening) since 1990 and Neuropathy (chronic condition worsening) since 2008. Concomitant products included TAMSULOSIN from 1990 to an unknown date, LISINOPRIL from 1998 to an unknown date, PRAVASTATIN SODIUM, GLIPIZIDE from 2008 to an unknown date, CARVEDILOL from 1998 to an unknown date, METFORMIN, CLOPIDOGREL, AMLODIPINE BESYLATE and CHONDROITIN SULFATE, GLUCOSAMINE (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE]) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced HYPOTENSION (Low blood pressure of 100/51). On 30-Jan-2021, the patient experienced HYPERHIDROSIS (Sweating), ASTHENIA (weakness) and CHILLS (Chills). On 01-Feb-2021, HYPOTENSION (Low blood pressure of 100/51) had resolved. At the time of the report, HYPERHIDROSIS (Sweating), ASTHENIA (weakness) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Blood glucose: 188 (Inconclusive) 188. On 29-Jan-2021, Blood pressure measurement: 100/51 (Low) 100/51 blood pressure has been going high and low and has not taken his BP medicines..     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment medication was taken. Patient stated that she didn't take blood pressure medication at that night.   This case was linked to MOD-2021-082574 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow-up received on 19-Apr-2021. The patient provided his Race as White and Ethnicity as Not Hispanic or Latino. The patient provided Medical history details  with High blood pressure and Diabetes as ongoing, Hyperlipidemia as no recent change in status of chronic condition, Benign Prostatic hyperplasia and Neuropathy as in worsening  status of chronic condition and the patient also had 2 strokes in the past. The patient provided the second dose details. The patient also provided several concomitant medication details. The adverse event outcome of Low BP after first dose and second dose was recovered.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blood cholesterol, Pain in extremity
Clinical narrative: sore arm, even more today; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm, even more today) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder and . Concomitant products included NICOTINIC ACID for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm, even more today). At the time of the report, PAIN IN EXTREMITY (sore arm, even more today) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: not provided Not provided.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Other Concomitant medications included Thyroid medicine and Cholesterol medicine.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Hyperhidrosis, Pyrexia
Clinical narrative: This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HYPERHIDROSIS (insane sweating (No fever)), DIZZINESS (dizzy), PYREXIA (fever), CHILLS (chills) and HEADACHE (headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 028L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No adverse event reported). On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced DIZZINESS (dizzy) and PYREXIA (fever). On 03-Feb-2021, the patient experienced HYPERHIDROSIS (insane sweating (No fever)), CHILLS (chills) and HEADACHE (headache). At the time of the report, HYPERHIDROSIS (insane sweating (No fever)), DIZZINESS (dizzy), PYREXIA (fever), CHILLS (chills) and HEADACHE (headache) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Reporter did not allow further contact
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Pain
Clinical narrative: dizziness; body pains; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), FATIGUE (fatigue), PAIN (body pains) and NAUSEA (nausea) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043l20a) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DIZZINESS (dizziness), FATIGUE (fatigue), PAIN (body pains) and NAUSEA (nausea). At the time of the report, DIZZINESS (dizziness), FATIGUE (fatigue), PAIN (body pains) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment medication included advil.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pain, Pyrexia
Clinical narrative: ache; felt without energy; fever (101.2 F); This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever (101.2 F)), PAIN (ache) and ASTHENIA (felt without energy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol (No reported adverse event).   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (fever (101.2 F)), PAIN (ache) and ASTHENIA (felt without energy). At the time of the report, PYREXIA (fever (101.2 F)), PAIN (ache) and ASTHENIA (felt without energy) outcome was unknown.            Concomitant medication included blood thinner medicine..  Treatment medication included Aspirin.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Disorientation, Fatigue, Headache
Clinical narrative: pain in opposite arm (right)/sore arm; disoriented; sweating; lethargy; headache; I had fatigue; chills; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy) and HEADACHE (headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy), HEADACHE (headache), FATIGUE (I had fatigue), CHILLS (chills) and ARTHRALGIA (joint pain). At the time of the report, PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy), HEADACHE (headache), FATIGUE (I had fatigue), CHILLS (chills) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Lethargy, Pain in extremity
Clinical narrative: pain in opposite arm (right)/sore arm; disoriented; sweating; lethargy; headache; I had fatigue; chills; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy) and HEADACHE (headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy), HEADACHE (headache), FATIGUE (I had fatigue), CHILLS (chills) and ARTHRALGIA (joint pain). At the time of the report, PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy), HEADACHE (headache), FATIGUE (I had fatigue), CHILLS (chills) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Headache, Illness, Nausea
Clinical narrative: she is extremely sick; abdominal pain/sharp pain; has severe headaches; nausea; got chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (she is extremely sick), ABDOMINAL PAIN (abdominal pain/sharp pain), HEADACHE (has severe headaches), NAUSEA (nausea) and CHILLS (got chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (she is extremely sick), ABDOMINAL PAIN (abdominal pain/sharp pain), HEADACHE (has severe headaches), NAUSEA (nausea) and CHILLS (got chills). At the time of the report, ILLNESS (she is extremely sick), ABDOMINAL PAIN (abdominal pain/sharp pain), HEADACHE (has severe headaches), NAUSEA (nausea) and CHILLS (got chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Erythema, Feeling abnormal, Feeling hot, Pruritus
Clinical narrative: Red area became bigger; Arm felt hot; Itchy; Small, red ball with pimples; Felt kind of weird; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), ACNE (Small, red ball with pimples), FEELING ABNORMAL (Felt kind of weird), ERYTHEMA (Red area became bigger) and FEELING HOT (Arm felt hot) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PRURITUS (Itchy), ACNE (Small, red ball with pimples) and FEELING ABNORMAL (Felt kind of weird). On 02-Feb-2021, the patient experienced ERYTHEMA (Red area became bigger) and FEELING HOT (Arm felt hot). At the time of the report, PRURITUS (Itchy), ACNE (Small, red ball with pimples), FEELING ABNORMAL (Felt kind of weird), ERYTHEMA (Red area became bigger) and FEELING HOT (Arm felt hot) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment for the event included ice.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: A hot bump; Itchiness / itchy bump; Redness / a red bump; Pain; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (A hot bump), VACCINATION SITE PRURITUS (Itchiness / itchy bump), VACCINATION SITE ERYTHEMA (Redness / a red bump), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness / itchy bump), VACCINATION SITE ERYTHEMA (Redness / a red bump), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling). On 28-Jan-2021, the patient experienced VACCINATION SITE WARMTH (A hot bump). On 23-Jan-2021, VACCINATION SITE PRURITUS (Itchiness / itchy bump), VACCINATION SITE ERYTHEMA (Redness / a red bump), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) had resolved. At the time of the report, VACCINATION SITE WARMTH (A hot bump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment was provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pain in extremity, Rash erythematous, Swelling
Clinical narrative: Red Rash; redness; swelling; a bit of sore arm; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a bit of sore arm), PAIN (Achiness), ERYTHEMA (redness), SWELLING (swelling) and RASH ERYTHEMATOUS (Red Rash) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K204 and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction (a history of anaphylaxis reaction from bees). Concurrent medical conditions included Bee sting hypersensitivity.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (a bit of sore arm) and PAIN (Achiness). On 02-Feb-2021, the patient experienced ERYTHEMA (redness) and SWELLING (swelling). On 03-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red Rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of UNK dosage form. On 10-Feb-2021, RASH ERYTHEMATOUS (Red Rash) had resolved. At the time of the report, PAIN IN EXTREMITY (a bit of sore arm), PAIN (Achiness), ERYTHEMA (redness) and SWELLING (swelling) outcome was unknown.            Concomitant product use was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2021: Significant follow up received on 23-Apr-2021
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Movement disorder, Oxygen saturation
Clinical narrative: morning, she could not get up and lift her arm; Felt bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt bad) and MOVEMENT DISORDER (morning, she could not get up and lift her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced FEELING ABNORMAL (Felt bad). On 05-Feb-2021, the patient experienced MOVEMENT DISORDER (morning, she could not get up and lift her arm). At the time of the report, FEELING ABNORMAL (Felt bad) and MOVEMENT DISORDER (morning, she could not get up and lift her arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Oxygen saturation: 89 (Low) 89.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Oxygen. The patient oxygen level was in 89 and with treatment it went up to 95, but it was fluctuating.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Headache; Fever; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever), CHILLS (chills) and FATIGUE (fatigue) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced HEADACHE (Headache), PYREXIA (Fever), CHILLS (chills) and FATIGUE (fatigue). The patient was treated with CHLORPHENAMINE MALEATE, IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE (ADVIL ALLERGY AND CONGESTION RELIEF) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache), PYREXIA (Fever), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Cough, Fatigue, Headache, Nausea
Clinical narrative: sore throat; loss of smell; cough; fatigue; nausea; headache; This spontaneous case was reported by a health care professional and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), ANOSMIA (loss of smell), COUGH (cough), FATIGUE (fatigue) and NAUSEA (nausea) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), ANOSMIA (loss of smell), COUGH (cough), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache). On 29-Jan-2021, OROPHARYNGEAL PAIN (sore throat), ANOSMIA (loss of smell), COUGH (cough), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants or treatment medications were reported.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: sore throat; loss of smell; cough; fatigue; nausea; headache; This spontaneous case was reported by a health care professional and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), ANOSMIA (loss of smell), COUGH (cough), FATIGUE (fatigue) and NAUSEA (nausea) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), ANOSMIA (loss of smell), COUGH (cough), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache). On 29-Jan-2021, OROPHARYNGEAL PAIN (sore throat), ANOSMIA (loss of smell), COUGH (cough), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants or treatment medications were reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash pruritic, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash), VACCINATION SITE WARMTH (warm to the touch at the injection site) and FATIGUE (fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FATIGUE (fatigue). On 28-Jan-2021, the patient experienced RASH PRURITIC (itchy rash) and VACCINATION SITE WARMTH (warm to the touch at the injection site). At the time of the report, RASH PRURITIC (itchy rash) outcome was unknown and VACCINATION SITE WARMTH (warm to the touch at the injection site) and FATIGUE (fatigue) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were provided. Treatment details included medicated lotion. Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: NNI: Reporter refused to give her Email ID/Fax number and took the call back number 1-866-663-3762; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: Rash that covered his whole body; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash that covered his whole body) and PAIN IN EXTREMITY (Sore arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Bladder infection (Diarrhea and rash on butt as a reaction to antibiotic.). Concurrent medical conditions included Cancer. Concomitant products included AMOXICILLIN for Bladder infection, LEUPRORELIN ACETATE (LUPRON) and PREDNISONE for Cancer.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced RASH (Rash that covered his whole body). At the time of the report, RASH (Rash that covered his whole body) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Myalgia, Vaccination site rash
Clinical narrative: light headed and dizziness; Body ache; chills; rash on the arm/rashes was still in her arm and was nowspreading all the way to the elbow; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headed and dizziness), VACCINATION SITE RASH (rash on the arm/rashes was still in her arm and was nowspreading all the way to the elbow), MYALGIA (Body ache) and CHILLS (chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Tylenol,Codeine) and Allergic to cats. Concomitant products included LORATADINE from 2000 to an unknown date for Allergic to cats.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE RASH (rash on the arm/rashes was still in her arm and was nowspreading all the way to the elbow). On 20-Jan-2021, the patient experienced MYALGIA (Body ache) and CHILLS (chills). On 17-Feb-2021, the patient experienced DIZZINESS (light headed and dizziness). On 03-Feb-2021, VACCINATION SITE RASH (rash on the arm/rashes was still in her arm and was nowspreading all the way to the elbow) had resolved. On 24-Feb-2021, DIZZINESS (light headed and dizziness) had resolved. At the time of the report, MYALGIA (Body ache) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2021-022053 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: No specific follow-up information recorded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: The site of injection is real itchy; Injection site was round; Injection site hard underneath; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (The site of injection is real itchy), VACCINATION SITE URTICARIA (Injection site was round) and VACCINATION SITE INDURATION (Injection site hard underneath) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (The site of injection is real itchy), VACCINATION SITE URTICARIA (Injection site was round) and VACCINATION SITE INDURATION (Injection site hard underneath). At the time of the report, VACCINATION SITE PRURITUS (The site of injection is real itchy), VACCINATION SITE URTICARIA (Injection site was round) and VACCINATION SITE INDURATION (Injection site hard underneath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Decreased appetite, Eating disorder, Vein discolouration
Clinical narrative: week of not really eating; Very bad stomach ache; Veins on the right side face all around his forehead and down the side turned blue; Trigeminal neuralgia worst it's ever been; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Very bad stomach ache), VEIN DISCOLOURATION (Veins on the right side face all around his forehead and down the side turned blue), CONDITION AGGRAVATED (Trigeminal neuralgia worst it's ever been) and EATING DISORDER (week of not really eating) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02862014) for COVID-19 vaccination.     Concurrent medical conditions included Trigeminal neuralgia (trigeminal neuralgia is on the left side). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), ATORVASTATIN and CARBAMAZEPINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced DECREASED APPETITE (Very bad stomach ache), VEIN DISCOLOURATION (Veins on the right side face all around his forehead and down the side turned blue) and CONDITION AGGRAVATED (Trigeminal neuralgia worst it's ever been). On 31-Jan-2021, the patient experienced EATING DISORDER (week of not really eating). At the time of the report, DECREASED APPETITE (Very bad stomach ache), VEIN DISCOLOURATION (Veins on the right side face all around his forehead and down the side turned blue), CONDITION AGGRAVATED (Trigeminal neuralgia worst it's ever been) and EATING DISORDER (week of not really eating) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided    Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up document was received. The primary reporter's contact information was updated. It contains non significant information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.